MBGE SEMINAR by Serkan Kýr

Time: 16:00
Location: ENG B29

Speaker          :
Dr. Serkan Kýr, Koç University

Title                : Dissecting Tumour-induced Signalling Pathways Driving Energy Wasting
Date                : September 20, 2018 Thursday
Time               : 16:00   
Cookie & Tea: 15:45 ENG B29
Place               : ENG B29

Abstract         :  Nearly half of all cancer patients suffer from cachexia, a wasting syndrome associated with elevated energy expenditure and the loss of adipose and skeletal muscle tissues. With no effective therapy against it, cancer cachexia has remained a devastating problem that reduces quality of life and limits therapy. Research in my laboratory aims to dissect the molecular mechanisms behind tumour signalling to adipose and muscle tissues and identify novel molecular targets for anti-cachexia therapy. Our work demonstrated that the tumour-derived factor Parathyroid hormone-related protein (PTHrP) triggers the browning of white fat tissue and promotes protein catabolism in skeletal muscle. Circulating PTHrP correlates with a greater degree of cachexia in cancer patients and the neutralization of this factor in tumour-bearing mice blocks adipose tissue browning and energy wasting while preserving muscle mass and strength. Recently, we have also discovered that Oncostatin M (OSM), another tumour-derived factor, induces atrophy in cultured muscle cells. OSM mediates a novel tumour-induced signalling pathway which appears to target both adipose and muscle tissues. We continue addressing the importance of PTHrP and OSM signalling in the aetiology of cancer cachexia with the overarching goal of studying therapeutic blockade of these pathways, which may prevent wasting in cancer patients.


Brief Bio         : Dr. Serkan Kýr received his PhD degree from the University of Texas Southwestern Medical Center at Dallas in 2011. He completed a Post-doctoral fellowship at Dana-Farber Cancer Institute/Harvard Medical School with Prof. Bruce Spiegelman and joined Koç University in 2017 as an Assistant Professor in the Department of Molecular Biology and Genetics. Dr. Kir’s research interests include adverse effects of tumours on host metabolism. His ongoing studies address tumour-driven hypermetabolism and the loss of adipose and skeletal muscle tissues. Dr. Kir identified PTHrP, a tumour-derived hormonal factor, as an inducer of energy wasting and adipose tissue atrophy. His laboratory currently investigates a missing link in tumour signalling to skeletal muscle that triggers the loss muscle mass and function. For more information please visit his laboratory website.